Skip to content

Clinical trials

Respiratory Syncytial Virus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Country / region: United States Clear all

143 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20043
20052
20061
20074
20081
20102
20115
20122
20135
20147
20158
20167
20176
20189
20199
20208
202110
202211
202316
202413
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed110
Terminated16
Recruiting7
Active, not recruiting4
Withdrawn3
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline28
National Institute of Allergy and Infectious Diseases (NIAID)23
Enanta Pharmaceuticals, Inc11
MedImmune LLC7
Gilead Sciences6
Sanofi Pasteur, a Sanofi Company6
Pfizer5
Novavax4
Alnylam Pharmaceuticals3
AstraZeneca3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections143
Respiratory Tract Infections6
COVID-195
Influenza, Human4
Virus Diseases3
Asthma2
Bronchiolitis2
Coronavirus Infections2
Pneumonia2
Acute Lung Injury1

Trials

Showing 26 to 50 of 143. Each trial links to its page on Pharma Observatory.

43 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.